P26.01.B A PHARMACOLOGICAL SURVEY ACROSS GLIOMA STEM CELL PHENOTYPES REVEAL NOVEL GLIOBLASTOMA DRUG-TARGETS, DRUG REPURPOSING OPPORTUNITIES AND FUTURE DRUG COMBINATION STRATEGIES

Richard Elliott; M Furqan; P Nagle; A Munro; C Drake; J c Dawson; V Brunton; M Frame; N O Carragher

doi:10.1093/neuonc/noae144.449

P26.01.B A PHARMACOLOGICAL SURVEY ACROSS GLIOMA STEM CELL PHENOTYPES REVEAL NOVEL GLIOBLASTOMA DRUG-TARGETS, DRUG REPURPOSING OPPORTUNITIES AND FUTURE DRUG COMBINATION STRATEGIES

Richard Elliott, M Furqan, P Nagle, A Munro, C Drake, J c Dawson, V Brunton, M Frame, N O Carragher

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	v132-v132
Journal	Neuro-Oncology
Volume	26
Issue number	Supplement_5
DOIs	https://doi.org/10.1093/neuonc/noae144.449
Publication status	Published - 17 Oct 2024

Access to Document

10.1093/neuonc/noae144.449Licence: Other

https://academic.oup.com/neuro-oncology/article/26/Supplement_5/v132/7825332

Edinburgh Drug Discovery
Unciti-Broceta, A. (Manager), Webster, S. (Manager) & Carragher, N. (Manager)
Deanery of Molecular, Genetic and Population Health Sciences
Facility/equipment: Facility

Cite this

Elliott, R., Furqan, M., Nagle, P., Munro, A., Drake, C., Dawson, J. C., Brunton, V., Frame, M., & Carragher, N. O. (2024). P26.01.B A PHARMACOLOGICAL SURVEY ACROSS GLIOMA STEM CELL PHENOTYPES REVEAL NOVEL GLIOBLASTOMA DRUG-TARGETS, DRUG REPURPOSING OPPORTUNITIES AND FUTURE DRUG COMBINATION STRATEGIES. Neuro-Oncology, 26(Supplement_5), v132-v132. https://doi.org/10.1093/neuonc/noae144.449

@article{cf0184d09cf844e2b47a03a16e3406fb,

title = "P26.01.B A PHARMACOLOGICAL SURVEY ACROSS GLIOMA STEM CELL PHENOTYPES REVEAL NOVEL GLIOBLASTOMA DRUG-TARGETS, DRUG REPURPOSING OPPORTUNITIES AND FUTURE DRUG COMBINATION STRATEGIES",

author = "Richard Elliott and M Furqan and P Nagle and A Munro and C Drake and Dawson, {J c} and V Brunton and M Frame and Carragher, {N O}",

year = "2024",

month = oct,

day = "17",

doi = "10.1093/neuonc/noae144.449",

language = "English",

volume = "26",

pages = "v132--v132",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "Supplement_5",

}

Elliott, R , Furqan, M , Nagle, P , Munro, A , Drake, C , Dawson, JC , Brunton, V , Frame, M & Carragher, NO 2024, 'P26.01.B A PHARMACOLOGICAL SURVEY ACROSS GLIOMA STEM CELL PHENOTYPES REVEAL NOVEL GLIOBLASTOMA DRUG-TARGETS, DRUG REPURPOSING OPPORTUNITIES AND FUTURE DRUG COMBINATION STRATEGIES', Neuro-Oncology, vol. 26, no. Supplement_5, pp. v132-v132. https://doi.org/10.1093/neuonc/noae144.449

P26.01.B A PHARMACOLOGICAL SURVEY ACROSS GLIOMA STEM CELL PHENOTYPES REVEAL NOVEL GLIOBLASTOMA DRUG-TARGETS, DRUG REPURPOSING OPPORTUNITIES AND FUTURE DRUG COMBINATION STRATEGIES. / Elliott, Richard ; Furqan, M ; Nagle, P et al.
In: Neuro-Oncology, Vol. 26, No. Supplement_5, 17.10.2024, p. v132-v132.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - P26.01.B A PHARMACOLOGICAL SURVEY ACROSS GLIOMA STEM CELL PHENOTYPES REVEAL NOVEL GLIOBLASTOMA DRUG-TARGETS, DRUG REPURPOSING OPPORTUNITIES AND FUTURE DRUG COMBINATION STRATEGIES

AU - Elliott, Richard

AU - Furqan, M

AU - Nagle, P

AU - Munro, A

AU - Drake, C

AU - Dawson, J c

AU - Brunton, V

AU - Frame, M

AU - Carragher, N O

PY - 2024/10/17

Y1 - 2024/10/17

U2 - 10.1093/neuonc/noae144.449

DO - 10.1093/neuonc/noae144.449

M3 - Meeting abstract

SN - 1522-8517

VL - 26

SP - v132-v132

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - Supplement_5

ER -

P26.01.B A PHARMACOLOGICAL SURVEY ACROSS GLIOMA STEM CELL PHENOTYPES REVEAL NOVEL GLIOBLASTOMA DRUG-TARGETS, DRUG REPURPOSING OPPORTUNITIES AND FUTURE DRUG COMBINATION STRATEGIES

Access to Document

Equipment

Edinburgh Drug Discovery

Cite this